NO924803L - Tumor-relatert monoklonalt antistoff 88bv59 - Google Patents

Tumor-relatert monoklonalt antistoff 88bv59

Info

Publication number
NO924803L
NO924803L NO92924803A NO924803A NO924803L NO 924803 L NO924803 L NO 924803L NO 92924803 A NO92924803 A NO 92924803A NO 924803 A NO924803 A NO 924803A NO 924803 L NO924803 L NO 924803L
Authority
NO
Norway
Prior art keywords
tumor
monoclonal antibody
monoclonal antibodies
related monoclonal
transformed
Prior art date
Application number
NO92924803A
Other languages
English (en)
Other versions
NO924803D0 (no
Inventor
Martin Victor Haspel
Barry Jay Kobrin
Virginia Zewe Crichton
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of NO924803D0 publication Critical patent/NO924803D0/no
Publication of NO924803L publication Critical patent/NO924803L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Denne oppfinnelse vedrører transformerte B-cellelinjer som stammer fra perifere blod B-celler fra kreftpasienter som er aktivt immunisert med autologe tumorantigen og de monoklonale antistoffene som de produserer. Disse monoklonale antistoffene kan benyttes til både diagnostiske fremgangsmåter og behandling av kreft hos mennesker.
NO92924803A 1991-12-13 1992-12-11 Tumor-relatert monoklonalt antistoff 88bv59 NO924803L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80730091A 1991-12-13 1991-12-13

Publications (2)

Publication Number Publication Date
NO924803D0 NO924803D0 (no) 1992-12-11
NO924803L true NO924803L (no) 1993-06-14

Family

ID=25196057

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924803A NO924803L (no) 1991-12-13 1992-12-11 Tumor-relatert monoklonalt antistoff 88bv59

Country Status (12)

Country Link
EP (1) EP0546634A3 (no)
JP (1) JP3539985B2 (no)
KR (1) KR930013103A (no)
AU (1) AU651261B2 (no)
CA (1) CA2083542A1 (no)
FI (1) FI925638A (no)
HU (1) HU218081B (no)
IL (1) IL103758A (no)
NO (1) NO924803L (no)
NZ (1) NZ245443A (no)
TW (1) TW271450B (no)
ZA (1) ZA928880B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001066754A1 (en) 2000-03-03 2001-09-13 Cambridge Antibody Technology Limited Human antibodies against eotaxin and their use
US6946546B2 (en) 2000-03-06 2005-09-20 Cambridge Antibody Technology Limited Human antibodies against eotaxin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4322879A (en) * 1978-01-11 1979-07-19 Massachusetts General Hospital, The Producing antibodies
US4172124A (en) 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4997762A (en) 1984-01-31 1991-03-05 Akzo N.V. Tumor associated monocoloal antibodies derived from human B-cell line
US4828991A (en) 1984-01-31 1989-05-09 Akzo N.V. Tumor specific monoclonal antibodies
NZ210867A (en) * 1984-01-31 1989-01-06 Litton Bionetics Inc Tumour-specific monoclonal antibodies, production thereof and use
WO1989000050A1 (en) * 1987-07-02 1989-01-12 Akzo N.V. Antigen recognized by mca 16-88

Also Published As

Publication number Publication date
IL103758A (en) 1998-07-15
HUT65480A (en) 1994-06-28
HU218081B (hu) 2000-05-28
JPH05317042A (ja) 1993-12-03
FI925638A (fi) 1993-06-14
EP0546634A3 (en) 1994-09-21
HU9203932D0 (en) 1993-04-28
NZ245443A (en) 1995-12-21
ZA928880B (en) 1993-08-12
JP3539985B2 (ja) 2004-07-07
AU651261B2 (en) 1994-07-14
FI925638A0 (fi) 1992-12-11
AU3008892A (en) 1993-06-17
NO924803D0 (no) 1992-12-11
KR930013103A (ko) 1993-07-21
IL103758A0 (en) 1993-04-04
TW271450B (no) 1996-03-01
CA2083542A1 (en) 1993-06-14
EP0546634A2 (en) 1993-06-16

Similar Documents

Publication Publication Date Title
DK40885D0 (da) Monoklonalt antistof, fremgangsmaade og celle til fremstilling deraf,fremgangsmaade til fremstilling af cellen og farmaceutisk praeparat indeholdende det monoklonale antistof
ES2120416T3 (es) Inhibidores del crecimiento tumoral derivados de tejidos, metodos de preparacion y usos de dichos inhibidores.
ATE101202T1 (de) Antikoerper.
DK164510C (da) Humant hybridom, humant monoklonalt antistof opnaaet derfra, anvendelse af et saadant antistof og fremgangsmaade til fremstilling af et saadant antistof
Gutterman et al. BCG stimulation of immune responsiveness in patients with malignant melanoma. Preliminary report
MD1374G2 (ro) Anticorpi monoclonali imunostimulatori, procedeu de obţinere a acestora, linii celulare, metodă de tratare a maladiilor şi compoziţie farmaceutică
US5700649A (en) Method of detection of urinary tumor associated antigen
Mathieson et al. T and B cell responses to neutrophil cytoplasmic antigens in systemic vasculitis
NO924803L (no) Tumor-relatert monoklonalt antistoff 88bv59
AU2070688A (en) Antigen recognized by mca 16-88
ATE138200T1 (de) Das von mca-28a32 erkannte antigen
FI935038A0 (fi) Tumoer associerad monoklonal antikropp 81AV78

Legal Events

Date Code Title Description
RE Reestablishment of rights (par. 72 patents act)
FC2A Withdrawal, rejection or dismissal of laid open patent application